81
Views
16
CrossRef citations to date
0
Altmetric
Miscellaneous

Aminolevulinic acid: pharmacological profile and clinical indication

, , , &
Pages 1139-1156 | Published online: 24 Feb 2005

Bibliography

  • BRAUN-FALCO 0, PLEWIG G, WOLFF HH: Dermatologe und Venerologie. Springer Verlag, Berlin, Heidelberg (1997).
  • BEUTNER KR, GEISSE JK, HELMAN D, FOX TL, GINKEL A, OWENS ML: Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% cream. j Am. Acad. Dermatol. (1999) 41:1002–1007.
  • LILLINGTON GA: Neoplasms of the lung. Curr. Opin. Pulm. Med (1999) 5:185–188.
  • LAMBERT R: Treatment of oesophageogastric tumors. Endoscopy (2000) 32:322–330.
  • MALMSTROM PU: Management of superficial bladder cancer: what is new? Curr. Opin. Urol. (2000) 10:447–451.
  • TIERNEY AC: Laparoscopic radical and partial nephrectomy. World j Urol. (2000) 18:249–256.
  • PRADOS MD, LEVIN V: Biology and treatment of malignant glioma. Semir]. Oncol. (2000) 27(3 Suppl. 6):1–10.
  • FRACKIEWICZ EJ: Endometriosis: an overview of the disease and its treatment. Am. Pharm. Assoc. (2000) 40:645–657.
  • JAKUS S, EDMONDS P, DUNTON C, KING SA: Margin status and excision of cervical intraepithelial neoplasia: a review. Obstet. Grieco]. Surv. (2000) 55:520–527.
  • KURWA HA, BARLOW RJ, NEILL S: Single episode photodynamic therapy and vulval intraepithelial neoplasia Type III resistant to conventional therapy. Br Dermatol. (2000) 143:1040–1042.
  • LAMBAH A, DIXON J: Breast cancer: detection and management. Practitioner (2000) 244:884–898.
  • MENON IA, PERSAD SD, HABERMANN HF: A comparison of the phototoxicity of protoporphyrin, coproporphyrin and uroporphyrin using a cellular system in vitro. CM. Biochem. (1989) 22:197–200.
  • PASS HI: Photodynamic therapy in oncology: Mechanism and clinical use. Natl. Cancer Inst. (1993) 85:443–456.
  • KICK G, MESSER G, GOETZ A, PLEWIG G, KIND P: Photodynamic therapy induces expression of interleukin 6 by activation of AP-1 but not NF-KB DNA binding. Cancer Res. (1995) 55:2373–2379.
  • LUNA MC, WONG S, GOMER CJ: Photodynamic therapy mediated induction of early response genes. Cancer Res. (1994) 54:1374–1380.
  • KLOTZ LO, FRITSCH C, BRIVIBA K, TSACMACIDIS N, SCHLIESS F, SIES H: Activation of JNK and p38 but not ERK MAP kinases in human skin cells by 5-aminolevulinate-photodynamic therapy. Cancer Res. (1998) 58:4297–300.
  • DELLIAN M, ABELS C, KUHNLE GE, GOETZ AE: Effects of photodynamic therapy on leucocyte-endothelium interaction: differences between normal and tumour tissue. Br. j Cancer (1995) 72:1125–1130.
  • KENNEDY JC, POTTIER RH, PROSS DC: Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. Photochem. Photobiol. B. Biol. (1990) 6:143–148.
  • DALTON JT, MEYER MC, GOLUB AL: Pharmacokinetics of aminolevulinic acid after oral and intravenous administration in dogs. Drug. Metab. Dispos. (1999) 27:432–435.
  • VAN DEN BOOGERT J, VAN HILLEGERSBERG R, DE ROOIJ FW et al.: 5-Aminolevulinic acid-induced protoporphyrin IX accumulation in tissues: pharmacokinetics after oral or intravenous administration. j Photochem. Photobiol. B. (1998) 44:29–38.
  • FRITSCH C, ABELS C, GOETZ AE etal.:Porphyrins preferentially accumulate in a melanoma following intravenous injection of 5-aminolevulinic acid. Biol. Chem. (1997) 378:51–57.
  • HERMAN MA, WEBBER J, FROMM D, KESSEL D: Hemodynamic effects of 5-aminolevulinic acid in humans. Photochem. Photobiol. B. (1998) 43:61–65.
  • RUDE, GEDERAAS 0, HOGSET A, BERG K: 5-Aminolevulinic acid, but not 5-aminolevulinic acid esters, is transported into adenocarcinoma cells by system BETA transporters. Photochem. Photobiol. (2000) 71:640–647.
  • LANGER S, ABELS C, BOTZLAR A et a/.:Active and higher intracellular uptake of 5-aminolevulinic acid in tumors may be inhibited by glycine. j Invest. Dermatol. (1999) 112:723–728.
  • FRITSCH C, LEHMANN P, STAHL W et al.: Optimum porphyrin accumulation in epithelial skin tumours and psoriatic lesions after topical application of delta-aminolaevulinic acid. Br j Cancer. (1999) 79:1603–1608.
  • PENG Q, WARLOE T, MOAN J et al.: Distribution of 5-aminolevulinic acid-induced porphyrins in noduloulcerative basal cell carcinoma. Photochem. Photobiol. (1995) 62:906–913.
  • BRAATHEN L, PAREDES B, FROHLICH K et al.:. A dose-finding study of photodynamic therapy (PDT) with Metvix® in actinic keratoses (AK). cur. Acad Dermatol. Venerol./EADV (2000) 14\(Suppl. 1):38.
  • BASSET-SEGUIN N, BACHMANN I, PAVEL S et al.: A dose-finding study of photodynamic therapy (PDT) with Metvix® in patients with basal cell carcinoma (BCC). Eur. Acad. Dermatol. Venerol./EADV (2000) 14\(Suppl. 1)39.
  • WOLF P, RIEGER E, KERL H: Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolevulinic acid: an alternative treatment modality for solar keratoses, superficial squamous cell carcinomas and basal cell carcinomas? j Am. Acad. Dermatol. (1993) 28:17–21.
  • FIJAN S, HONIGSMANN H, ORTEL B: Photodynamic therapy of epithelial skin tumours using 8-aminolaevulinic acid and desferrioxamine. Br j Dermatol. (1995) 133:282–288.
  • CALZAVARA-PINTON PG: Repetitive photodynamic therapy with topical d-aminolaevulinic acid as an appropriate approach to the routine treatment of superficial non-melanoma skin tumours. Photochem. Photobiol. B: Biol. (1995) 29:53–57.
  • JEFFES EW, MCCULLOUGH JL, WEINSTEIN GD et al.: Photodynamic therapy of actinic keratosis with topical 5-aminolevulinic acid. A pilot dose-ranging study. Arch. Dermatol. (1997) 133:727–732.
  • ITOH Y, NINOMIYA Y, HENTA T, TAJIMA S, ISHIBASHI A: Topical delta-aminolevulinic acid-based photodynamic therapy for Japanese actinic keratoses. Dermatol. (2000) 27:513–518.
  • FRITSCH C, HOMEY B, STAHL W, LEHMANN P, RUZICKA T, SIES H: Preferential relative porphyrin enrichment in solar keratoses upon topical application of delta-aminolevulinic acid methylester. Photochem. Photobiol. (1998) 68:218–21.
  • FRITSCH C, GOERZ G, RUZICKA T: Photodynamic therapy in dermatology. Arch. Dermatal (1998) 134:207–214.
  • CAIRNDUFF F, STRINGER MR, HUDSON EJ, ASH DV, BROWN SB: Superficial photodynamic therapy with topical 5-aminolevulinic acid for superficial primary and secondary skin cancer. Br. Cancer (1994) 69:605–608.
  • WENNBERG AM, LINDHOLM LE, ALPSTEN M, LARKO 0: Treatment of superficial basal cell carcinomas using topically applied 8-aminolaevulinic acid and a filtered xenon lamp. Arch. Dermatal Res. (1996) 88:561–564.
  • MORTON CA, WHTEHURST C, MOSELEY H, MCCOLL JH, MOORE JV, MACKIE RM: Comparison of photodynamic therapy with cryotherapy in the treatment of Bowen's disease. Br Dermatal (1996) 135:766–771.
  • ROBINSON PJ, CARRITH JAS, FAIRRISGM: Photodynamic therapy: a better treatment for widespread Bowen's disease. Br. J Dermatal (1988) 119:59–61.
  • PENNINGTON DG, WANERM, KNOX A: Photodynamic therapy for multiple skin cancers. Plast Reconstr. &mg. (1988) 82:1067–1071.
  • BUCHANAN RB, CARRUTH JAS, MCKENZIE AL, WILLIAMS SR: Photodynamic therapy in the treatment of malignant tumours of the skin and head and neck. Eur. &mg. aka (1989) 15:400–406.
  • ALLEN RP KESSEL D, THARRATT RS, VOLZ W: Photodynamic therapy of superficial malignancies with Npe6 in man. In: Photodynamic Therapy and Biomedical Lasers. Spinelli P, Dal Fante M, Marchesini R (Eds.).Elsevier, Holland (1992) 441–445.
  • HARTH Y, HIRSHOVITZ B: Topical photodynamic therapy in basal and squamous cell carcinoma and penile Bowen's disease with 20% aminolevulinic acid and exposure to red light and infrared light. Harefuah. (1998) 134:602-605,672,671.
  • WARLOE T, PENG Q, MOAN J, QVIST HL, GIERICKSKY KE: Photochemotherapy of multiple basal cell carcinoma with endogenous porphyrins induced by topical application of 5-aminolevulinic acid. In: Photodynamic therapy and biochemical lasers. Spinelli P, Dal Fante M, Marchesini R (Eds.). Elsevier, Holland. (1992) 449–453.
  • FRITSCH C, NEUMANN NJ, RUZICKA T, LEHMANN P: Photodiagnostic test methods III. Fluorescence diagnosis with aminolevulinic acid induced porphyrins. Hautarzt (2000) 51:528–545.
  • TOPE WD, ROSS EV, KOLLIAS N, MARTIN A, GILLIES R, ANDERSON RR: Protoporphyrin IX fluorescence induced in basal cell carcinoma by oral delta-aminolevulinic acid. Photochem. Photabial (1998) 67:249–255.
  • FINK-PUCHES R, WOLF P, KERL H: Photodynamic therapy of superficial basal cell carcinoma by instillation of aminolevulinic acid and irradiation with visible light. Arch. Dermatal. (1997) 133:1494–1495.
  • FRITSCH C, BECKER-WEGERICH PM,MENKE H, RUZICKA T, GOERZ G, OLBRISCH RR: Successful surgery of multiple recurrent basal cell carcinomas guided by photodynamic diagnosis. Aesthetic. Plast. &mg. (1997) 21:437–439.
  • FRITSCH C, LANG K, NEUSE W, RUZICKA T, LEHMANN P: Photodynamic diagnosis and therapy in dermatology. Skin Pharmacal Appl Skin Physial (1998) 11:358-373. (Review).
  • LUI H, ANDERSON RR: Photodynamic therapy in dermatology: recent developments. Dermatal Clin. (1993) 11:1–13.
  • WOLF P, KERL H: Photodynamic therapyon a patient with xeroderma pigmentosum. Lancet (1991) 337:1613–1614.
  • WOLF P, FINK-PUCHES R, CERRONI L, KERL H: Photodynamic therapy for mycosis fungoides after topical photosensitization with 5-aminolevulinic acid. J Am. Acad. Dermatal (1994) 31:678–680.
  • AMMANN R, HUNZIKER T: Photodynamic therapy for mycosis fungoides after topical photosensitization with 5-aminolevulinic acid. j Am. Acad. Dermatal (1995) 33:541.
  • HENTA T, ITOH Y, KOBAYASHI M, NINOMIYA Y, ISHIBASHI A: Photodynamic therapy for inoperable vulval Paget's disease using 8-aminolaevulinic acid: successful management of a large skin lesion. Br j Dermatal (1999) 141:347–349.
  • BECKER-WEGERICH PM, FRITSCH C,SCHULTE KW et al: Carbon dioxide laser treatment of extramammary Paget's disease guided by photodynamic diagnosis. Br Dermatal. (1998) 138:169–172.
  • STENDER IM, WULF HC: Photodynamic therapy with 5-aminolevulinic acid in the treatment of actinic cheilitis. Br. j Dermatal (1996) 135:454–456.
  • STABLES GI, STRINGER MR, ASH DV: The treatment of erythroplasia of Queyrat by topical aminolevulinic acid photodynamic therapy. Br j Dermatal (1995) 133\(Suppl. 45):30.
  • LEUNIG A, BETZ CS, BAUMGARTNER R, GREVERS G, ISSING WJ: Initial experience in the treatment of oral leukoplakia with high-dose vitamin A and follow-up 5-aminolevulinic acid induced protoporphyrin IX fluorescence. Eur. Arch. Otorhinalarytigal (2000) 257:327–331.
  • KUBLER A, HAASE T, RHEINWALD M, BARTH T, MUHLING J: Treatment of oral leukoplakia by topical application of 5-aminolevulinic acid. Int. j Oral. Maxillafac. &mg. (1998) 27:466–469.
  • LEUNIG A, BETZ CS, MEHLMANN M et al: Detection of squamous cell carcinoma of the oral cavity by imaging 5-aminolevulinic acid-induced protoporphyrin IX fluorescence. Laryngoscope (2000) 110:78–83.
  • ZENK W, DIETEL W, SCHLEIER P, GUNZEL S: Visualizing carcinomas of the mouth cavity by stimulating synthesis of fluorescent protoporphyrin IX. Mund Kiefer Gesichischir. (1999) 3:205–209.
  • BOEHNCKE WH, ELSHORST-SCHMIDT T, KAUFMANN R: Systemic photodynamic therapy is a safe and effective treatment for psoriasis. Arch. Dermatal (2000) 136:271–272.
  • ROBINSON DJ, COLLINS P, STRINGER MR et al: Improved response of plaque psoriasis after multiple treatments with topical 5-aminolaevulinic acid photodynamic therapy. Acta. Berm. Venereal (1999) 79:451–455.
  • BOEHNCKE WH, STERRY W, KAUFMANN R: Treatment of psoriasis by topical photodynamic therapy with polychromatic light. Lancet (1994) 343:801.
  • MEFFERT H, GAUNITZ K, GUTEWORT T, AMLONG UJ: Therapy of acne with visible light. Decreased irradiation time by using a blue-light high-energy lamp. Dermatal Monatsschr. (1990) 176:597–603.
  • HONGCHARU W, TAYLOR CR, CHANG Y, AGHASSI D, SUTHAMJARIYA K, ANDERSON RR: Topical ALA-photodynamic therapy for the treatment of acne vulgaris. j Invest. Dermatol (2000) 115:183–192.
  • KARRER S, ABELS C, LANDTHALER M, SZEIMIES RIVI: Topical photodynamic therapy for localized scleroderma. Acta. Berm. Verrerol. (2000) 80:26–27.
  • SMETANA Z, MALIK Z, ORENSTEIN A, MENDELSON E, BEN-HUR E: Treatment of viral infections with 5-aminolevulinic acid and light. Lasers &mg. Med. (1997) 21:351–358.
  • STENDER IM, NA R, FOGH H, GLUUD C, WULF HC: Photodynamic therapy with 5-aminolaevulinic acid or Placebo for recalcitrant foot and hand warts: randomised double-blind trial. Lancet (2000) 355:963–966.
  • AMMANN R, HUNZIKER T, BRAATHEN LR: Topical photodynamic therapy in verrucae. A pilot study. Dermatology (1995) 191:346–347.
  • FEHR MK, CHAPMAN CF, KRASIEVA T etal.: Selective photosensitizer distribution in vulvar condyloma acuminatum after topical application of 5-aminolevulinic acid. Am. j Obstet. Cyrrecol (1996) 174:951–957.
  • FRANK RG, BOS JD: Photodynamic therapy for condylomata acuminata with local application of 5-aminolevulinic acid. Cerritounh. Med. (1996) 72:70–71.
  • ROSS EV, ROMERO R, KOLLIAS N, CRUM C, ANDERSON RR: Selectivity of protoporphyrin IX fluorescence for condylomata after topical application of 5-aminolaevulinic acid: implications for photodynamic treatment. Br j Dermatol (1997) 137:736–742.
  • GROSSMAN M, WIMBERLY J, DWYER P, FLOTTE T, ANDERSON RR: PDT of hirsutism. Lasers. &mg. Med. (1995) 7:44.
  • MALIK E, BERG C, MEYHOFER-MALIK A, BUCHWEITZ 0, MOUBAYED P, DIEDRICH K: Fluorescence diagnosis of endometriosis using 5-aminolevulinic acid. &mg. Enclose. (2000) 14:452–455.
  • HILLEMANNS P, WEINGANDT H, BAUMGARTNER R, DIEBOLD J, XIANG W, STEPP H: Photodetection of cervical intraepithelial neoplasia using 5-aminolevulinic acid-induced porphyrin fluorescence. Cancer (2000) 88:2275–2282.
  • HILLEMANNS P, UNTCH M, DANNECKER C et al: Photodynamic therapy of vulvar intraepithelial neoplasia using 5-aminolevulinic acid. Irm j Cancer (2000) 85:649–653.
  • FEHR MK, HORNUNG R, SCHWARZ VA, SIMEON R, HALLER U, WYSS P: Photodynamic therapy of vulvar intraepithelial neoplasia III using topically applied 5-aminolevulinic acid. Cyrrecol arca (2001) 80:62–66.
  • LADNER DP, STEINER RA, ALLEMANN J, HALLER U, WALT H: Photodynamic diagnosis of breast tumours after oral application of aminolevulinic acid. Br. J. Cancer (2001) 84:33–37.
  • ACKROYD R, BROWN N, VERNON D et al: 5-Aminolevulinic acid photosensitization of dysplastic Barrett's esophagus: a pharmacokinetic study. Photochem. Photobiol. (1999) 70:656–662.
  • MESSMANN H, KNUCHEL R, BAUMLER W, HOLSTEGE A, SCHLMERICH J: Endoscopic fluorescence detection of dysplasia in patients with Barrett's esophagus, ulcerative colitis, or adenomatous polyps after 5-aminolevulinic acid-induced protoporphyrin IX sensitization. Castrointest. Enclose. (1999) 49:97–101.
  • MAYINGER B, REH H, HOCHBERGER J, HAHN EG: Endoscopic photodynamic diagnosis: oral aminolevulinic acid is a marker of GI cancer and dysplastic lesions. Castrointest. Enclose. (1999) 50:242–246.
  • GOSSNER L, MAY A, SROKA R, STOLTE M, HAHN EG, ELL C: Photodynamic destruction of high grade dysplasia and early carcinoma of the esophagus after the oral administration of 5-aminolevulinic acid. Cancer (1999) 86:921–928.
  • KASHTAN H, KONIKOFF E HADDAD R, SKORNICK Y: Photodynamic therapy of cancer of the esophagus using systemic aminolevulinic acid and a non laser light source: a Phase I/II study. Castrointest. Enclose. (1999) 49:760–764.
  • TAN WC, FULLJAMES C, STONE N et al.: Photodynamic therapy using 5-aminolaevulinic acid for oesophageal adenocarcinoma associated with Barrett's metaplasia. j Photochem. Photobiol B. (1999) 53:75–80
  • RIEDL CR, PLAS E, PFLUGER H: Fluorescence detection of bladder tumors with 5-amino-levulinic acid. j Endourol (1999) 13:755–759.
  • KRIEGMAIR M, ZAAK D, STEPP H et al.: Transurethral resection and surveillance of bladder cancer supported by 5-aminolevulinic acid-induced fluorescence endoscopy. Eur. Ural (1999) 36:386–392.
  • POPKEN G, WETTERAUER U, SCHULTZE-SEEMANN W: Kidney-preserving tumour resection in renal cell carcinoma with photodynamic detection by 5-aminolaevulinic acid: preclinical and preliminary clinical results. EN Int. (1999) 83:578–582.
  • STUMMER W, STOCKERS, WAGNER S et al.: Intraoperative detection of malignant gliomas by 5-aminolevulinic acid-induced porphyrin fluorescence. Neurosurgery (1998) 42:518-525 (Discussion 525–526).
  • STUMMER W, NOVOTNY A, STEPP H,GOETZ C, BISE K, REULEN HJ: Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients. j Neurosurg. (2000) 93:1003–1013.
  • OMROD D, JARVIS B: Topical aminolevulinic acid HCL photodynamic therapy. Am. I Clin. Dermatol (2000) 1:133–139.
  • KURWA HA, YONG-GEE SA, SEED PT, MARKEY AC, BARLOW RJ: A randomized paired comparison of photodynamic therapy and topical 5-fluorouracil in the treatment of actinic keratoses. j Am. Acad. Dermatol (1999) 41:414–418.
  • WOLF P, WULF HC, WARLOE T etal.: Apivotal study of photodynamic therapy with Metvix cream 160 mg/g in patients with basal cell carcinoma unsuitable to conventional therapy. (2001) (In press).
  • SZEIMIES RM, RADAKOVIC S, CALZAVARA-PINTON PG et al: A prospective, randomized study comparing photodynamic therapy (PDT) with Metvix®, to cryotherapy in actinic keratoses (AK). Eur. Acad. Dermatol Verrerol/EADV (2000) 14 (Suppl. 1):235.
  • STUMMERW, MEINEL T, REULEN HJ: Fluoresenzgestützte Resektion maligner Gliome. Phase-3-Studie mit 5-aminolavulinsaure. Dt. Arziebt. (2001) 98A:407.
  • FRITSCH C, VERWOHLT B, BOLSEN K, RUZICKA T, GOERZ G: Influence of topical photodynamic therapy with 5-aminolevulinic acid on porphyrin metabolism. Arch. Dermatol Res. (1996) 288:517–521.
  • GNIAZDOWSKA B, RUEFF F, HILLEMANNS P, PRZYBILLA B: Allergic contact dermatitis from delta-aminolevulinic acid used for photodynamic therapy. Contact Dermatitis (1998) 38:348–349.
  • FRITSCH C, STEGE H, SAALMANN G, GOERZ G, RUZICKA T, KRUTMANN J: Green light is effective and less painful than red light in photodynamic therapy of facial solar keratoses. Photodennata Photoirranurrol. Photomed. (1997) 13:181–185.
  • FRITSCH C, BECKER-WEGERICH PM,SCHULTE KW LEHMANN E RUZICKA T, GOERZ G: Treatment of a large superficial basal cell carcinoma of the breast. Combination of photodynamic therapy and surgery controlled by photodynamic diagnosis. Hautarzt (1996) 47:438–442.
  • ORENSTEIN A, KOSTENICH G, TSUR H, KOGAN L, MALIK Z: Temperature monitoring during photodynamic therapy of skin tumors with topical 5-aminolevulinic acid application. Cancer Lett. (1995) 93:227–232.
  • REGULA J, MACROBERT AJ, GORCHEIN A etal.: Photosensitisation and photodynamic therapy of oesophageal, duodenal and colorectal tumours using 5 aminolaevulinic acid induced protoporphyrin IX--a pilot study. Cut (1995) 36:67–75.
  • VERWANGER T, SSCHNITZHOFER G, KRAMMER B: Expression kinetics of the (proto) oncogenes c-myc and bc1-2 following photodynamic treatment of normal and transformed human fibroblasts with 5-aminolaevulinic acid-stimulated endogenous protoporphyrin IX. j. Photochern. Photobia B. (1998) 45:131–135.
  • MARCUS SL, SOBEL RS, GOLUB AL, CARROLL RL, LUNDAHL S, SHULMAN DG: Photodynamic therapy (PDT) and photodiagnosis (PD) using endogenous photosensitization induced by 5-aminolevulinic acid (ALA): current clinical and development status. j. Clirr. Laser Med. Surg. (1996) 14:59-66. (Review).
  • BUCHCZYK DE KLOTZ LO, LANG K, FRITSCH C, SIES S: High efficiency of 5-aminolevulinate-photodynamic treatment using UVA-irradiation. Carcirrogerresis. (In press).
  • STENDER IM, WULF HC: Kobner reaction induced by photodynamic therapy using 8-aminolevulinic acid. A case report. Acta. Dena Venereal. (1996) 76:392-393. Affiliation

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.